Background Programmed death ligand 1 (PD-L1) blockade offers new therapeutic options for oesophageal squamous cell carcinoma ...

Long-lasting antibody responses depend on immune cells that are difficult to observe inside living human tissue. An ...

BioCytics, Inc., has engaged Eremid® Genomic Services to help sequence an autologous immune cell fraction that is the leading candidate of BioCytics' immune-based cancer cell therapy efforts. Eremid ...

Researchers at Wake Forest University School of Medicine have identified a protein that may help an aggressive form of breast ...

A routine blood sample contains a diverse collection of immune cells that can reveal important clues about health and disease ...

Some worn-out cells don’t quietly retire. They linger in tissues, release inflammatory signals and may make it harder for ...

A new MS cell therapy uses a patient's own red blood cells to retrain the immune system, helping protect myelin and reduce brain inflammation, a study shows.

Scientists have discovered that some severe genetic disorders linked to rapid aging may be driven not just by damaged DNA, ...

Cancer is the second-leading cause of death in the United States, according to a 2026 Cancer Research Institute report.

Discover how integrating proteomics with cellular and molecular profiling can provide a systems-level view of host–pathogen ...